2001
Vascular and extravascular complications of liver transplantation: comprehensive evaluation with three-dimensional contrast-enhanced volumetric MR imaging and MR cholangiopancreatography.
Pandharipande P, Lee V, Morgan G, Teperman L, Krinsky G, Rofsky N, Roy M, Weinreb J. Vascular and extravascular complications of liver transplantation: comprehensive evaluation with three-dimensional contrast-enhanced volumetric MR imaging and MR cholangiopancreatography. American Journal Of Roentgenology 2001, 177: 1101-7. PMID: 11641180, DOI: 10.2214/ajr.177.5.1771101.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAnastomosis, SurgicalAngiography, Digital SubtractionCholangiographyCholestasis, ExtrahepaticCommon Bile Duct DiseasesFemaleHumansImage Processing, Computer-AssistedImaging, Three-DimensionalLiverLiver TransplantationMagnetic Resonance AngiographyMagnetic Resonance ImagingMaleMiddle AgedPostoperative ComplicationsSensitivity and SpecificityVascular DiseasesConceptsDigital subtraction angiographyMR cholangiopancreatographyLiver transplantSubtraction angiographyMR imagingVolumetric MR imagingConsecutive adult patientsSubset of patientsHepatocellular carcinoma recurrenceMR angiography examinationsMR imaging examinationsBiliary complicationsDisease underestimationExtrahepatic complicationsLiver transplantationAbnormal findingsAdult patientsCarcinoma recurrenceMR imaging strategiesAngiography examinationsVascular diseaseImaging examinationsMost recipientsCholangiopancreatographySimultaneous vascularHepatocellular Carcinoma and Dysplastic Nodules in Patients with Cirrhosis: Prospective Diagnosis with MR Imaging and Explantation Correlation
Krinsky G, Lee V, Theise N, Weinreb J, Rofsky N, Diflo T, Teperman L. Hepatocellular Carcinoma and Dysplastic Nodules in Patients with Cirrhosis: Prospective Diagnosis with MR Imaging and Explantation Correlation. Radiology 2001, 219: 445-54. PMID: 11323471, DOI: 10.1148/radiology.219.2.r01ma40445.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCarcinoma, HepatocellularFalse Positive ReactionsFemaleHumansLiverLiver CirrhosisLiver NeoplasmsMagnetic Resonance ImagingMaleMiddle AgedSensitivity and SpecificityConceptsHepatocellular carcinomaDysplastic nodulesMR imagingHistory of HCCSpecificity of MRDetection of HCCMagnetic resonanceDiagnosis of tumorsHepatic arterialHepatic malignanciesPathologic resultsHepatic neoplasmsProspective diagnosisGradient-echo MR imagesMR image interpretationPatient basisLesion basisMR imagesPatientsSubsequent transplantationSpin-echo MR imagesLesions 1Overall sensitivitySiderotic Nodules in the Cirrhotic Liver at MR Imaging with Explant Correlation: No Increased Frequency of Dysplastic Nodules and Hepatocellular Carcinoma
Krinsky G, Lee V, Nguyen M, Rofsky N, Theise N, Morgan G, Teperman L, Weinreb J. Siderotic Nodules in the Cirrhotic Liver at MR Imaging with Explant Correlation: No Increased Frequency of Dysplastic Nodules and Hepatocellular Carcinoma. Radiology 2001, 218: 47-53. PMID: 11152778, DOI: 10.1148/radiology.218.1.r01ja4047.Peer-Reviewed Original Research
2000
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging
Federle M, Chezmar J, Rubin D, Weinreb J, Freeny P, Schmiedl U, Brown J, Borrello J, Lee J, Semelka R, Mattrey R, Dachman A, Saini S, Harms S, Mitchell D, Anderson M, Halford H, Bennett W, Young S, Rifkin M, Gay S, Ballerini R, Sherwin P, Robison R. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging. Journal Of Magnetic Resonance Imaging 2000, 12: 689-701. PMID: 11050638, DOI: 10.1002/1522-2586(200011)12:5<689::aid-jmri5>3.0.co;2-z.Peer-Reviewed Original ResearchConceptsUnenhanced magnetic resonance imagingMagnetic resonance imagingMangafodipir trisodium injectionFinal diagnosisMulticenter phase III clinical trialContrast-enhanced computed tomography examinationPhase III clinical trialsContrast-enhanced magnetic resonance imagingInjection of MnDPDPPatient's final diagnosisHepatic magnetic resonance imagingComputed tomography examinationEnhanced magnetic resonance imagingFocal liver diseaseAdditional diagnostic informationFocal liver lesionsLiver diseaseEarly imagingMRI evaluationHepatic massClinical trialsTomography examinationIntravenous administrationPatient managementRadiologic diagnosisPelvic arteriovenous malformations: gadolinium-enhanced three-dimensional MR angiography findings
Candamio M, Lee V, Rofsky N, Krinsky G, Weinreb J. Pelvic arteriovenous malformations: gadolinium-enhanced three-dimensional MR angiography findings. European Radiology 2000, 10: 1257-1260. PMID: 10939485, DOI: 10.1007/s003300000329.Peer-Reviewed Original ResearchSafety and Efficacy of Mangafodipir Trisodium (MnDPDP) Injection for Hepatic MRI in Adults: Results of the U.S. Multicenter Phase III Clinical Trials (Safety)
Federle M, Chezmar J, Rubin D, Weinreb J, Freeny P, Semelka R, Brown J, Borrello J, Lee J, Mattrey R, Dachman A, Saini S, Harmon B, Fenstermacher M, Pelsang R, Harms S, Mitchell D, Halford H, Anderson M, Johnson C, Francis I, Bova J, Kenney P, Klippenstein D, Foster G, Turner D, Stillman A, Nelson R, Young S, Patt R, Rifkin M, Seltzer S, Gay S, Robison R, Sherwin P, Ballerini R. Safety and Efficacy of Mangafodipir Trisodium (MnDPDP) Injection for Hepatic MRI in Adults: Results of the U.S. Multicenter Phase III Clinical Trials (Safety). Journal Of Magnetic Resonance Imaging 2000, 12: 186-197. PMID: 10931579, DOI: 10.1002/1522-2586(200007)12:1<186::aid-jmri21>3.0.co;2-2.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal PainAdultAgedAged, 80 and overCardiovascular DiseasesContrast MediaDiagnosis, DifferentialEdetic AcidFemaleHumansImage EnhancementInjections, IntravenousLiver CirrhosisLiver NeoplasmsMagnetic Resonance ImagingMaleMiddle AgedPainPregnancyPyridoxal PhosphateRisk AssessmentSensitivity and SpecificityVomitingConceptsMagnetic resonance imagingMangafodipir trisodium injectionAdverse eventsMulticenter phase III clinical trialContrast-enhanced computed tomography examinationPhase III clinical trialsUnenhanced magnetic resonance imagingInjection of MnDPDPInjection-associated discomfortSerious adverse eventsShort-term safetyHepatic magnetic resonance imagingComputed tomography examinationSignificant short-term riskShort-term riskFocal liver lesionsClinical trialsTomography examinationLaboratory valuesLiver lesionsResonance imagingVital signsPatientsMnDPDPInjectionAngiotensin-converting enzyme inhibitor-enhanced phase-contrast MR imaging to measure renal artery velocity waveforms in patients with suspected renovascular hypertension.
Lee V, Rofsky N, Ton A, Johnson G, Krinsky G, Weinreb J. Angiotensin-converting enzyme inhibitor-enhanced phase-contrast MR imaging to measure renal artery velocity waveforms in patients with suspected renovascular hypertension. American Journal Of Roentgenology 2000, 174: 499-508. PMID: 10658731, DOI: 10.2214/ajr.174.2.1740499.Peer-Reviewed Original Research
1999
Echo‐train STIR MRI of the liver: Comparison of breath‐hold and non‐breath‐hold imaging strategies
Earls J, Rofsky N, DeCorato D, Krinsky G, Weinreb J. Echo‐train STIR MRI of the liver: Comparison of breath‐hold and non‐breath‐hold imaging strategies. Journal Of Magnetic Resonance Imaging 1999, 9: 87-92. PMID: 10030655, DOI: 10.1002/(sici)1522-2586(199901)9:1<87::aid-jmri12>3.0.co;2-5.Peer-Reviewed Original Research
1997
Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography.
Rofsky N, Johnson G, Adelman M, Rosen R, Krinsky G, Weinreb J. Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography. Radiology 1997, 205: 163-9. PMID: 9314979, DOI: 10.1148/radiology.205.1.9314979.Peer-Reviewed Original ResearchConceptsPeripheral vascular diseaseGadolinium-enhanced MR angiographyDigital subtraction angiographyVascular diseaseMR angiographyGadopentetate dimeglumineLower extremity peripheral vascular diseasePeripheral vascular areasExtent of diseaseMR angiography findingsGadolinium-enhanced magnetic resonance angiographyMagnetic resonance angiographyConventional digital subtraction angiographyStandard of referenceAngiography findingsMost patientsLess stenosisTreatment optionsLower extremitiesDSA findingsVascular areaAngiographyAnatomic segmentsAnatomic areasContrast material
1996
CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II.
Zerhouni E, Rutter C, Hamilton S, Balfe D, Megibow A, Francis I, Moss A, Heiken J, Tempany C, Aisen A, Weinreb J, Gatsonis C, McNeil B. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 1996, 200: 443-51. PMID: 8685340, DOI: 10.1148/radiology.200.2.8685340.Peer-Reviewed Original ResearchConceptsComputed tomographyColorectal carcinomaLiver metastasesMR imagingLocal-regional lymph nodesAssessment of lymphAccuracy of CTLocal extentMagnetic resonanceRecent technologic advancesLymph nodesRectal cancerRectal tumorsTransmural penetrationMuscularis propriaPrimary tumorColon cancerGroup IITransmural extentTumorsMR studiesCarcinomaTechnologic advancesStagingPatients
1995
Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group.
Megibow A, Zhou X, Rotterdam H, Francis I, Zerhouni E, Balfe D, Weinreb J, Aisen A, Kuhlman J, Heiken J. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group. Radiology 1995, 195: 327-32. PMID: 7724748, DOI: 10.1148/radiology.195.2.7724748.Peer-Reviewed Original ResearchConceptsComputed tomographyT1-weighted spin-echo sequencesMR imagingPredictive valueSpin-echo sequenceCross-sectional imaging modalitiesInitial imaging assessmentUnresectable pancreatic carcinomaEvaluation of resectabilityAccuracy of CTT2-weighted spin-echo sequencesNegative predictive valuePositive predictive valueMagnetic resonanceAdult patientsOncology GroupHepatic metastasesVascular invasionPathologic resultsPancreatic adenocarcinomaImaging assessmentPancreatic carcinomaCT scanImaging modalitiesAdenocarcinoma
1994
Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging.
Mitchell D, Saini S, Weinreb J, De Lange E, Runge V, Kuhlman J, Parisky Y, Johnson C, Brown J, Schnall M. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 1994, 193: 49-57. PMID: 8090921, DOI: 10.1148/radiology.193.1.8090921.Peer-Reviewed Original ResearchControversies in breast MRI.
Weinreb J, Newstead G. Controversies in breast MRI. Magnetic Resonance Quarterly 1994, 10: 67-83. PMID: 7986702.Peer-Reviewed Original ResearchMeSH KeywordsAgedBreast NeoplasmsFemaleHumansMagnetic Resonance ImagingMammographyMiddle AgedSensitivity and Specificity
1993
Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
Rofsky N, Weinreb J, Bernardino M, Young S, Lee J, Noz M. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. Radiology 1993, 188: 53-9. PMID: 8390072, DOI: 10.1148/radiology.188.1.8390072.Peer-Reviewed Original Research
1992
Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
Bernardino M, Young S, Lee J, Weinreb J. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. Radiology 1992, 183: 53-8. PMID: 1549694, DOI: 10.1148/radiology.183.1.1549694.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overContrast MediaEdetic AcidFemaleHumansLiverLiver DiseasesMagnetic Resonance ImagingMaleMiddle AgedPyridoxal PhosphateSensitivity and SpecificityConceptsMn-DPDPMore lesionsAdditional lesionsT1-weighted imagesDose groupSerious side effectsMagnetic resonance imagingT2-weighted imagesFocal hepatic diseaseN'-dipyridoxylethylenediamineIntravenous bolusHepatic diseaseMultiinstitutional studyPatientsSide effectsLesionsResonance imagingHepatic MRManganese NImaging parametersContrast agentsImagingGroupInfusionBolus
1990
Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT.
Birnbaum B, Weinreb J, Megibow A, Sanger J, Lubat E, Kanamuller H, Noz M, Bosniak M. Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT. Radiology 1990, 176: 95-101. PMID: 2191377, DOI: 10.1148/radiology.176.1.2191377.Peer-Reviewed Original ResearchConceptsSingle-photon emission CTMR imagingHepatic hemangiomaPerfusion blood pool mismatchMajor hepatic vesselsCases MR imagingT2-weighted spin-echo MR imagesPhoton emission CTMagnetic resonance imagingDiagnosis of lesionsLesion signal intensityRed blood cellsDefinitive diagnosisHypervascular metastasesTc-99mHemangiomaSpin-echo MR imagesEmission CTHepatic vesselsResonance imagingBlood cells